234 related articles for article (PubMed ID: 36115888)
1. Updated trabecular bone score accounting for the soft tissue thickness (TBS
Hans D; Shevroja E; McDermott M; Huang S; Kim M; McClung M
Osteoporos Int; 2022 Dec; 33(12):2517-2525. PubMed ID: 36115888
[TBL] [Abstract][Full Text] [Related]
2. Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension.
Hans D; McDermott M; Huang S; Kim M; Shevroja E; McClung M
Osteoporos Int; 2023 Jun; 34(6):1075-1084. PubMed ID: 36862192
[TBL] [Abstract][Full Text] [Related]
3. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.
Senn C; Günther B; Popp AW; Perrelet R; Hans D; Lippuner K
Osteoporos Int; 2014 Jul; 25(7):1945-51. PubMed ID: 24760244
[TBL] [Abstract][Full Text] [Related]
5. Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial.
Tsai JN; Jiang LA; Lee H; Hans D; Leder BZ
J Clin Densitom; 2017; 20(4):507-512. PubMed ID: 28624340
[TBL] [Abstract][Full Text] [Related]
6. Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
Bilezikian JP; Hattersley G; Fitzpatrick LA; Harris AG; Shevroja E; Banks K; Leder BZ; Zanchetta JR; Hans D
Osteoporos Int; 2018 Feb; 29(2):323-328. PubMed ID: 29167971
[TBL] [Abstract][Full Text] [Related]
7. Contributions of Clinical and Technical Factors to Longitudinal Change in Trabecular Bone Score and Bone Density: A Registry-Based Individual-Level Analysis.
Leslie WD; Goel H; Binkley N; McCloskey EV; Hans D
J Bone Miner Res; 2023 Apr; 38(4):512-521. PubMed ID: 36655775
[TBL] [Abstract][Full Text] [Related]
8. Trabecular Bone Score (TBS) Varies with Correction for Tissue Thickness Versus Body Mass Index: Implications When Using Pediatric Reference Norms.
Valenzuela Riveros LF; Long J; Bachrach LK; Leonard MB; Kent K
J Bone Miner Res; 2023 Apr; 38(4):493-498. PubMed ID: 36779634
[TBL] [Abstract][Full Text] [Related]
9. Effect of denosumab on trabecular bone score in de novo kidney transplant recipients.
Bonani M; Frey D; Graf N; Wüthrich RP
Nephrol Dial Transplant; 2019 Oct; 34(10):1773-1780. PubMed ID: 30932161
[TBL] [Abstract][Full Text] [Related]
10. Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study.
Popp AW; Guler S; Lamy O; Senn C; Buffat H; Perrelet R; Hans D; Lippuner K
J Bone Miner Res; 2013 Mar; 28(3):449-54. PubMed ID: 23018784
[TBL] [Abstract][Full Text] [Related]
11. Effect of Abaloparatide on Bone Microarchitecture Assessed by Trabecular Bone Score in Women With Osteoporosis: Post Hoc Analysis of ACTIVE and ACTIVExtend.
Cosman F; Hans D; Shevroja E; Wang Y; Mitlak B
J Bone Miner Res; 2023 Apr; 38(4):464-470. PubMed ID: 36588166
[TBL] [Abstract][Full Text] [Related]
12. Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy.
Kalder M; Kyvernitakis I; Albert US; Baier-Ebert M; Hadji P
Osteoporos Int; 2015 Jan; 26(1):353-60. PubMed ID: 25381047
[TBL] [Abstract][Full Text] [Related]
13. 3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate.
Lewiecki EM; Betah D; Humbert L; Libanati C; Oates M; Shi Y; Winzenrieth R; Ferrari S; Omura F
J Bone Miner Res; 2024 May; 39(4):473-483. PubMed ID: 38477808
[TBL] [Abstract][Full Text] [Related]
14. Effects of Teriparatide and Sequential Minodronate on Lumbar Spine Bone Mineral Density and Microarchitecture in Osteoporosis.
Miyaoka D; Imanishi Y; Ohara M; Hayashi N; Nagata Y; Yamada S; Mori K; Emoto M; Inaba M
Calcif Tissue Int; 2017 Oct; 101(4):396-403. PubMed ID: 28589205
[TBL] [Abstract][Full Text] [Related]
15. Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis.
Hong N; Shin S; Lee S; Rhee Y
Osteoporos Int; 2023 Dec; 34(12):2059-2067. PubMed ID: 37596432
[TBL] [Abstract][Full Text] [Related]
16. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.
Bone HG; Wagman RB; Brandi ML; Brown JP; Chapurlat R; Cummings SR; Czerwiński E; Fahrleitner-Pammer A; Kendler DL; Lippuner K; Reginster JY; Roux C; Malouf J; Bradley MN; Daizadeh NS; Wang A; Dakin P; Pannacciulli N; Dempster DW; Papapoulos S
Lancet Diabetes Endocrinol; 2017 Jul; 5(7):513-523. PubMed ID: 28546097
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal changes in bone mineral density and trabecular bone score following yearly zoledronic acid infusion in postmenopausal osteoporosis-a retrospective-prospective study from southern India.
Sooragonda B; Cherian KE; Jebasingh FK; Dasgupta R; Asha HS; Kapoor N; Thomas N; Paul TV
Arch Osteoporos; 2019 Jul; 14(1):79. PubMed ID: 31321603
[TBL] [Abstract][Full Text] [Related]
18. Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.
Shevroja E; Lamy O; Kohlmeier L; Koromani F; Rivadeneira F; Hans D
J Clin Densitom; 2017; 20(3):334-345. PubMed ID: 28734710
[TBL] [Abstract][Full Text] [Related]
19. Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging.
Shevroja E; Reginster JY; Lamy O; Al-Daghri N; Chandran M; Demoux-Baiada AL; Kohlmeier L; Lecart MP; Messina D; Camargos BM; Payer J; Tuzun S; Veronese N; Cooper C; McCloskey EV; Harvey NC
Osteoporos Int; 2023 Sep; 34(9):1501-1529. PubMed ID: 37393412
[TBL] [Abstract][Full Text] [Related]
20. Trabecular bone score in the hip: a new method to examine hip bone microarchitecture-a feasibility study.
Haeri NS; Perera S; Ferreiro I; Hans D; Greenspan SL
Arch Osteoporos; 2022 Sep; 17(1):126. PubMed ID: 36125566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
